Global Point Of Care Infectious Disease Diagnostics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 2.20 Billion |
 Market Size (Forecast Year) |
USD 6.42 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球即时诊断传染病市场，按产品（消耗品、仪器、软件和服务）、技术（横向流动、凝集测定、流通和固相）、应用（艾滋病毒、热带病、肝病、炎症性疾病、呼吸系统疾病、医院相关感染和性健康障碍）、最终用户（医院、医疗中心、实验室、独立诊断中心和家庭护理环境）划分——行业趋势和预测到 2031 年。
即时诊断传染病市场分析及规模
即时诊断传染病市场正在经历显著增长，这得益于全球医疗机构对快速、准确诊断解决方案的需求不断增长。这些诊断对于及时发现和管理疾病至关重要，尤其是对于传染病，及时干预对于防止传播和改善患者治疗效果至关重要。诊断技术的进步推动了该市场的发展，包括分子诊断、免疫测定和快速抗原检测，这些技术可以在患者的即时诊断点或附近进行快速有效的检测。即时诊断传染病解决方案使医疗保健提供者能够快速诊断感染、启动适当的治疗并实时监测患者的反应，从而减轻集中实验室的负担并提高医疗保健效率。
2023 年全球即时传染病诊断市场规模价值 22 亿美元，预计到 2031 年将达到 64.2 亿美元，预测期内复合年增长率为 2024 年至 2031 年。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022 (可定制为 2016-2021) |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品（耗材、仪器、软件和服务）、技术（横向流动、凝集试验、流通和固相）、应用（艾滋病毒、热带病、肝病、炎症性疾病、呼吸道疾病、医院相关感染和性健康障碍）、最终用户（医院、医疗中心、实验室、独立诊断中心和家庭护理环境） |
|
覆盖国家 |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America |
|
Market Players Covered |
Siemens Healthineers AG (Germany), Trivitron Healthcare (India), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), Quest Diagnostics Incorporated (U.S.), BD (U.S.), Chembio Diagnostics, Inc. (U.S.), Trinity Biotech (Ireland), Cardinal Health (U.S.), Bio-Rad Laboratories Inc. (U.S.), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), OJ-Bio Limited (U.K.) |
|
Market Opportunities |
|
Market Definition
Point of care infectious disease diagnostics refers to diagnostic tests performed at or near the patient's location, typically within a healthcare setting such as a clinic, doctor's office, or field setting, rather than in a centralized laboratory. These tests are designed to provide rapid and accurate results, enabling healthcare providers to make immediate treatment decisions. POC IDD technologies encompass a variety of methods, including molecular diagnostics, immunoassays, and rapid diagnostic tests (RDTs).
Point of Care Infectious Disease Diagnostics Market Dynamics
Drivers
- Demand for Rapid Diagnosis
The increasing demand for rapid diagnostic solutions in healthcare settings is driven by the urgent need to detect infectious diseases swiftly at the point of care. These solutions enable healthcare providers to promptly initiate appropriate treatments, thereby improving patient outcomes and reducing transmission risks within communities. Rapid diagnostic tests (RDTs), molecular diagnostics, and antigen tests are pivotal in diagnosing infections such as influenza, tuberculosis and emerging outbreaks such as COVID-19. This demand is particularly critical in emergency departments, clinics, and remote areas where immediate diagnosis can significantly impact disease management and public health outcomes.
- Increasing Prevalence of Infectious Diseases
The global rise in infectious diseases, exacerbated by factors such as population growth, urbanization, and international travel, underscores the importance of adopting point-of-care diagnostics for infectious diseases. Infectious disease outbreaks, including pandemics like COVID-19, highlight the necessity for rapid and accurate diagnostic tools that can quickly identify pathogens and facilitate timely intervention strategies. POC IDD solutions play a crucial role in surveillance, early detection, and containment efforts, empowering healthcare systems to effectively manage disease spread and mitigate public health crises through targeted interventions and preventive measures.
Opportunities
- Development of Multiplex Assays
Advancements in multiplex assay technologies are transforming Point of Care Infectious Disease Diagnostic (POC IDD) devices. These assays allow simultaneous detection of multiple pathogens or biomarkers in a single test, boosting diagnostic efficiency and broadening the applications of POC IDD devices. By consolidating testing procedures and cutting turnaround times, multiplex assays help healthcare providers quickly make informed decisions, especially during complex clinical situations or outbreaks where identifying several pathogens swiftly is crucial. This innovation not only enhances diagnostic accuracy but also improves how healthcare resources are used and creates new market opportunities.
- Integration with Digital Health Platforms
Linking POC IDD devices with digital health platforms opens up new possibilities for healthcare delivery. By connecting diagnostic data with electronic health records (EHRs), telemedicine platforms, and real-time monitoring systems, healthcare providers can streamline workflows, enhance patient care, and enable remote consultations. This digital integration makes it easier to transmit diagnostic results, improving access to healthcare services, particularly in remote or underserved areas where traditional infrastructure may be lacking, creating new opportunities for the point of care infectious disease diagnostics market.
Restraints/Challenges
- Regulatory Challenges
Stringent regulatory requirements for the approval and commercialization of POC IDD devices present significant challenges for manufacturers and market entry. Compliance with diverse regulatory frameworks across different regions necessitates comprehensive testing, validation, and documentation, adding complexity and time to the product development lifecycle. Regulatory barriers can impede innovation and market access, particularly for novel technologies or devices seeking global deployment.
- Accuracy and Reliability Concerns
Concerns regarding the accuracy and reliability of POC IDD devices compared to laboratory-based assays remain a critical consideration for healthcare providers and regulatory bodies. Variability in test performance under different environmental conditions, operator proficiency, and specimen quality can impact diagnostic accuracy and reliability, potentially influencing clinical decision-making.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In October 2023, QIAGEN achieved CE certification for its IVD kit and automated testing platform, NeuMoDx. This development significantly boosted the company’s revenue and market share
- In May 2023, Danaher Corporation introduced the Dxl 9000 Access Immunoassay Analyzer capable of processing up to 215 tests per hour. This launch expanded the company’s offerings in point-of-care diagnostics
- In May 2023, BD announced 510k clearance for its BD Kiestra Methicillin-resistant Staphylococcus aureus (MRSA) imaging application, which incorporates AI software. This innovation reduces test result turnaround times by automating the labor-intensive process of identifying bacterial growth traditionally done using petri dishes
Point of Care Infectious Disease Diagnostics Market Scope
The market is segmented on the basis of product, technology, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Instruments
- Software and Services
Technology
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
Application
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections
- Sexual Health Disorders
End User
- Hospitals
- Healthcare Centers
- Laboratories
- Independent Diagnostic Centers
- Home Care Settings
Point of Care Infectious Disease Diagnostics Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, product, technology, application, and end user as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to a significant rise in the adoption of testing instruments in hospitals to meet the growing demand for point-of-care diagnostics for various infectious diseases. The availability of robust healthcare and medical facilities, coupled with heightened awareness and the presence of skilled professionals, further consolidates its position as the dominant market.
Asia-Pacific is expected to witness significant growth during the forecast period due to ongoing investments in healthcare infrastructure and other medical advancements. This growth is characterized by expanding access to healthcare facilities, increased investment in medical technologies, and enhanced healthcare services. These developments contribute significantly to the region's emerging prominence in the healthcare sector.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Point of Care Infectious Disease Diagnostics Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
市场上的一些主要参与者包括：
- 西门子医疗股份公司（德国）
- Trivitron Healthcare（印度）
- F. Hoffmann-La Roche Ltd（瑞士）
- 雅培（美国）
- Quest Diagnostics Incorporated（美国）
- BD（美国）
- Chembio Diagnostics Inc.（美国）
- Trinity Biotech（爱尔兰）
- 康德乐 (美国)
- Bio-Rad Laboratories Inc.（美国）
- 生物梅里埃公司（法国）
- 赛默飞世尔科技公司（美国）
- Quidel Corporation（美国）
- OJ-Bio Limited（英国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
